{"product_id":"global-tuberculosis-tb-diagnostics-market-growth-status-and-outlook-2023-2029","title":"Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eTuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term \"consumption\" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Tuberculosis (TB) Diagnostics Industry Forecast” looks at past sales and reviews total world Tuberculosis (TB) Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis (TB) Diagnostics sales for 2023 through 2029. With Tuberculosis (TB) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis (TB) Diagnostics industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Tuberculosis (TB) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis (TB) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis (TB) Diagnostics market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis (TB) Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis (TB) Diagnostics.\u003c\/p\u003e\n\n\u003cp\u003eThe global Tuberculosis (TB) Diagnostics market size is projected to grow from US$ 2572.8 million in 2022 to US$ 3540.9 million in 2029; it is expected to grow at a CAGR of 4.7% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.\u003c\/p\u003e\n\n\u003cp\u003eAPAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.\u003c\/p\u003e \n\n\u003cp\u003eIn terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Diagnostics market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003c\/p\u003e\n\n \u003cp\u003eCulture-Based Diagnostics\u003c\/p\u003e\n\n \u003cp\u003eSputum Smear Microscopy\u003c\/p\u003e\n\n \u003cp\u003eRapid Molecular Diagnostics\u003c\/p\u003e\n\n \u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003c\/p\u003e\n\n \u003cp\u003eDiagnostic Laboratories\u003c\/p\u003e\n\n \u003cp\u003eHospitals\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003c\/p\u003e\n\n \u003cp\u003eAmericas\u003c\/p\u003e\n\n \u003cp\u003eUnited States\u003c\/p\u003e\n\n \u003cp\u003eCanada\u003c\/p\u003e\n\n \u003cp\u003eMexico\u003c\/p\u003e\n\n \u003cp\u003eBrazil\u003c\/p\u003e\n\n \u003cp\u003eAPAC\u003c\/p\u003e\n\n \u003cp\u003eChina\u003c\/p\u003e\n\n \u003cp\u003eJapan\u003c\/p\u003e\n\n \u003cp\u003eKorea\u003c\/p\u003e\n\n \u003cp\u003eSoutheast Asia\u003c\/p\u003e\n\n \u003cp\u003eIndia\u003c\/p\u003e\n\n \u003cp\u003eAustralia\u003c\/p\u003e\n\n \u003cp\u003eEurope\u003c\/p\u003e\n\n \u003cp\u003eGermany\u003c\/p\u003e\n\n \u003cp\u003eFrance\u003c\/p\u003e\n\n \u003cp\u003eUK\u003c\/p\u003e\n\n \u003cp\u003eItaly\u003c\/p\u003e\n\n \u003cp\u003eRussia\u003c\/p\u003e\n\n \u003cp\u003eMiddle East \u0026amp; Africa\u003c\/p\u003e\n\n \u003cp\u003eEgypt\u003c\/p\u003e\n\n \u003cp\u003eSouth Africa\u003c\/p\u003e\n\n \u003cp\u003eIsrael\u003c\/p\u003e\n\n \u003cp\u003eTurkey\u003c\/p\u003e\n\n \u003cp\u003eGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003c\/p\u003e\n\n \u003cp\u003eDanaher\u003c\/p\u003e\n\n \u003cp\u003eRoche\u003c\/p\u003e\n\n \u003cp\u003eThermo Fisher Scientific\u003c\/p\u003e\n\n \u003cp\u003eBD\u003c\/p\u003e\n\n \u003cp\u003eAbbott\u003c\/p\u003e\n\n \u003cp\u003eHologic\u003c\/p\u003e\n\n \u003cp\u003eQiagen\u003c\/p\u003e\n\n \u003cp\u003eBioMerieux\u003c\/p\u003e\n\n \u003cp\u003eHain Lifescience\u003c\/p\u003e\n\n \u003cp\u003eOxford Immunotec\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 104 Pages \/ MCW16234407","offer_id":47650945663282,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-tuberculosis-tb-diagnostics-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}